Astria Therapeutics, Inc. announced that it has named John Ruesch as Senior Vice President, Pharmaceutical Sciences and Technical Operations. Mr. Ruesch brings to Astria more than 25 years of experience in pharmaceutical drug development. Mr. Ruesch most recently served as Vice President, Pharmaceutical Development at Surface Oncology.

Prior to that, he held several roles at Biogen, Inc., including Vice President, Protein Technical Development, Senior Director, Head of Protein Technical Development, and Senior Director, Drug Product Development. Prior to Biogen, he worked at Pfizer from 2003 to 2015 in positions of increasing responsibility, culminating in his role as Senior Director, Formulation and Drug Product Process Development. Mr. Ruesch holds his B.S. in Biology from Valparaiso University, and his M.B.A. from Northwestern University Kellogg School of Management.